Protara Therapeutics, Inc. — Director's Dealing 2022

Jul 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2022-07-16

Reporting Person: Fry Hannah (VP, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-16	Common Stock	A	25000	$0.00	Acquired	27600	Direct

Footnotes

F1: The shares being reported are being issued pursuant to a restricted stock unit (RSU) award, of which each RSU represents a contingent right to receive one share of Issuer's common stock. The RSUs vest one hundred percent (100%) on the first anniversary of July 16, 2022.